Svena Verma, PhD

Graduate Student

Svena Verma, PhD

Graduate Student

Share
Print
Share
Print
Svena Verma

Oncogenic signaling resulting in altered metabolic activity is considered a major contributor to the suppressive nature of the tumor microenvironment. I work with melanoma pre-clinical models to better understand the dynamic relationships between oncogenic signaling, downstream tumor metabolism, and resulting immune cell function. Notably, I’m interested in therapies targeting cancer glycolysis in combination with immune checkpoint blockade, and how these therapies can rationally be applied to patients.